DaVita (DVA) Tops Q1 EPS by 36c, Offers FY Guidance
Get Alerts DVA Hot Sheet
Price: $178.47 +2.18%
Revenue Growth %: +2.6%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +2.6%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q1 EPS of $1.83, $0.36 better than the analyst estimate of $1.47. Revenue for the quarter came in at $2.84 billion versus the consensus estimate of $2.8 billion.
GUIDANCE:
DaVita sees FY2020 EPS of $5.75-$6.25, versus the consensus of $6.02. DaVita sees FY2020 revenue of $11.5-11.7 billion, versus the consensus of $11.65 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Paychex (PAYX) Tops Q1 EPS by 2c
- RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share